In TAM reprogramming that mediates immune activation by activated CD8+ T cells, depletion of macrophages reduces the effectiveness of therapeutic cancer vaccination, and in this case, TAM targeting techniques need to be carefully combined [149]. The gene discussed is CD8A; the disease is cancer.